"ABCG2 could serve as a predictor of gemcitabine response and potentially as a chemotherapeutic target in pancreatic cancer. Inhibition of ERK1/2 and HIF-1alphacould result in increased gemcitabine sensitization in pancreatic cancer with highly expressed ABCG2 cell member protein."xsd:string